Inscriere cercetatori

Premii Ad Astra

premii Ad Astra

Asociația Ad Astra a anunțat câștigătorii Premiilor Ad Astra 2022: http://premii.ad-astra.ro/. Proiectul și-a propus identificarea și popularizarea modelelor de succes, a rezultatelor excepționale ale cercetătorilor români din țară și din afara ei.

Asociatia Ad Astra a cercetatorilor romani lanseaza BAZA DE DATE A CERCETATORILOR ROMANI DIN DIASPORA. Scopul acestei baze de date este aceea de a stimula colaborarea dintre cercetatorii romani de peste hotare dar si cu cercetatorii din Romania. Cercetatorii care doresc sa fie nominalizati in aceasta baza de date sunt rugati sa trimita un email la cristian.presura@gmail.com

Carmen Cristina Diaconu

Avatar

Stefan S. Nicolau Institute of Virology, Bucuresti, .

E-mail: trimite un mesaj.

Pagina web a instituţiei: http://www.virology.ro

Urmareste linkul ResearcherID pentru toate articolele cercetatorului: B-9119-201 . Tabelul detaliat al articolelor este in josul paginii.

Nascut(a) in: 1967

Interese: patologie celulara si moleculara, genetica moleculara, semnalizare, virusologie

flag Detalii:
Experienta extinsa, dobandita in diferite echipe multinationale, pe teme de genetica moleculara, semnalizare intracelulara, patologie celulara si moleculara si virusologie. Experienta in aceste domenii a fost dobandita in cursul unor stagii de lunga durata cu burse obtinute de la International Training Course on Selected Topics of Modern Biology, Institute of Genetics, Szeged, Hungary (UNESCO/ICRO fellowship si Qualitas Biologica Hungary); Alexander von Humboldt Fellowship pentru cercetatori juniori (postdoc) - Special Program Stability Pact for South-Eastern Europe, Institute of Human Genetics, Bonn, Germany; postdoctoral in medicina experimentala la Ludwig Inst. for Cancer Research, Brussels, UCL, Belgium si de asemenea, in cursul unor specializari de scurta durata la Inst. of Mol Biotechnology, Jena, Germania; Univ of Oxford, GB; Univ of Bonn, Germania,University of Antwerp, Belgia, University of San Diego, La Jolla, SUA. Rezultate semnificative au fost obtinute in domeniul dezvoltarii de noi metode investigative, identificarii de markeri de diagnostic si al semnalizarii intracelulare, celule stem/progenitoare, identificare/screening de noi medicamente.

flag Details:
Extensive experience in working in various multinational teams on molecular genetics, signal transduction, cellular and molecular pathology and virology topics. Experience in these fields was gained especially during long term fellowships like: International Training Course on Selected Topics of Modern Biology, Institute of Genetics, Szeged, Hungary (UNESCO/ICRO fellowship and Qualitas Biologica Hungary); Alexander von Humboldt Fellowship for junior scientist (postdoc) - Special Program Stability Pact for South-Eastern Europe,Institute of Human Genetics, Bonn, Germany; postdoctoral fellowship in experimental medicine at Ludwig Inst. for Cancer Research, Brussels, UCL, Belgium, and also in some short-term trainings at Inst. of Mol Biotechnology, Jena, Germany; Univ of Oxford, UK, Univ of Bonn, Germany, University of Antwerp, Belgium, University of San Diego, La Jolla, USA. Significant results were in the fields of development of new methods of investigation, molecular markers for diagnostic, signal transduction, stem/progenitor cells, new drugs identification/screening.

Publicații selectate:

* Pecquet C, Diaconu CC, Staerk J, Girardot M, Marty C, Royer Y, Defour JP, Dusa A, Besancenot R, Giraudier S, Villeval JL, Knoops L, Courtoy PJ, Vainchenker W, Constantinescu SN., Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes, American Society of Hematology, Blood, 119 (20), 2012.

* Meng Ling Choong, Christian Pecquet, Vishal Pendharkar, Carmen C. Diaconu, Jacklyn Wei Yan Yong. Shi Jing Tai, Si Fang Wang, Jean-Philippe Defour, Kanda Sangthongpitag, Jean-Luc Villeval, William Vainchenker, Stefan N. Constantinescu, May Ann Lee, Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors, Wiley, Journal of Cellular and Molecular Medicine, 17 (11), 2013.

* Diaconu, C. C., Szathmari, M., Keri, G., Venetianer, A. , Programmed cell death (apoptosis) is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analog TT 232, Nature Publishing Group, British J. Cancer, 80(8), 1999.